Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositol

Anticancer Research

Volumn 19, Issue 5 A, 1999, Pages 3663-3664

  Nishino, Hoyoku ^a   Murakoshi, Michiaki ^a,b   Masuda, Mitsuharu ^a   Tokuda, Harukuni ^a   Satomi, Yoshiko ^a   Onozuka, Mari ^a   Yamaguchi, Shino ^a   Bu, Ping ^a   Tsuruta, Atsushi ^a   Nosaka, Kazuto ^a   Baba, Masaki ^c   Takasuka, Nobuo ^d  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b LION CORPORATION   (Japan)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Chemoprevention; Liver carcinogenesis; Myo inositol

Indexed keywords

INOSITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER INCIDENCE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; LIVER CANCER; LIVER CARCINOGENESIS; LUNG CARCINOGENESIS; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; INOSITOL; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C3H;

EID: 0032778789     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Vucenic I, Yang G-Y and Shamsuddin AM: Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis 16: 1055-1058, 1995.
2. Estensen RD and Wattenherg LW: Studies of chemopreventive effects of myo-inositol on benz[α]pyrene-induced neoplasia of the lung and forestomach of female A/J mice. Carcinogenesis 14: 1975-1977, 1993.